Brimonidine Tartrate
CAS 70359-46-5 11 FDA-DMF suppliersSmall Molecule
Overview
Brimonidine Tartrate is an alpha-2 adrenergic receptor agonist primarily used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by decreasing the production of aqueous humor and increasing uveoscleral outflow.
API suppliers (15)
Suppliers of Brimonidine Tartrate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- FARMAK AS1 active DMF
- MEDICHEM SASpain1 active DMF
- FARMAK AS1 active DMF
- MEDICHEM SASpain1 active DMF
- Piramal Pharma LimitedIndia1 active DMF
- MEDICHEM SASpain1 active DMF
- FARMAK AS1 active DMF
- Piramal Pharma LimitedIndia1 active DMF
- SYMED LABS LTDIndia1 active DMF
- Piramal Pharma LimitedIndia1 active DMF
- SYMED LABS LTDIndia1 active DMF
- C-SQUARED PHARMA LTD1 active DMF
- SIEGFRIED GRAFTON INC1 active DMF
- Unichem Laboratories Ltd.India1 active DMF
- Lupin LimitedIndia
Therapeutic areas
OphthalmologyGlaucoma TreatmentOptic Pressure Management
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.